Modulation of NF-κB, p53 and Bcl-2 in apoptosis induced by cisplatin in HeLa cells

https://doi.org/10.1016/S0027-5107(97)00150-4Get rights and content

Abstract

Cisplatin exposure induces apoptosis in HeLa cells. Since the interaction of this drug with DNA produces reactive oxygen species, we performed an analysis of the oxidative stress-responsive factors AP-1 and NF-κB. Although AP-1 levels were not modified during cisplatin exposure, electrophoretic mobility shift assays demonstrated an increase in NF-κB DNA binding activity that correlated with a decrease of the inhibitory protein IκBα and a specific relocalization of c-Rel, as assessed by immunoblotting and immunofluorescence. No changes in the levels or localization of p65 were found. Interestingly, IκBα relocalized to the nucleus, probably in order to regulate the binding of specific complexes. This process was accompanied by a decrease of the antiapoptotic protein Bcl-2, and a relocalization of p53 protein to the nucleus. Since HeLa cells lost most of their p53 protein due to a specific E6-dependent degradation, cisplatin could be inhibiting this degradation, since the p53 total levels were not increased during the exposure to the drug.

Introduction

Apoptosis is an active cell death process. Morphologically, it is characterized by condensation of nuclear chromatin and cytoplasm, and formation of membrane-enclosed apoptotic bodies, containing well-preserved organelles. The biochemical hallmark of apoptosis is the formation of distinct DNA fragments of oligonucleosomal size (180–200 bp) 1, 2. The process is active and requires specific gene regulation. A critical role for p53 in the execution of some forms of apoptosis has been suggested 3, 4, 5, 6, 7. This protein is a sequence-specific DNA-binding protein, active as a transcription factor. It has been proposed that p53 may be involved in the cellular response to DNA damage, producing arrest in the G1 phase of the cell cycle to allow efficient repair of the DNA before entry to S phase, or cell death if the damage is too large to be repaired [3]. Cells containing negligible amounts of wild-type p53 protein as a result of specific degradation induced by infection with human papillomavirus, or cells expressing mutant p53, are not able to arrest the cell cycle progression and continue to proliferate, leading to genetic instability and eventually malignancy [4]. Another gene implicated in apoptosis is Bcl-2 [8]. The Bcl-2 gene product functions as an anti-apoptotic signal, suppressing apoptosis induced by a wide variety of stimuli, including chemotherapeutic drugs and γ radiation 9, 10. The exact mechanism of Bcl-2 in preventing apoptosis is still not clear. However, Bcl-2 has been implicated in cellular control of their redox state11, 12.

Apoptosis plays a role in a number of disease processes, including cancer. It has been suggested that antineoplastic drugs may exert their effects by inducing apoptotic cell death. In this regard cisplatin (CDDP) has been shown to induce apoptosis in diverse cell lines 13, 14, 15. The drug is an effective crosslinking agent that generates: intra- and inter-strand DNA crosslinks, DNA–protein crosslinks, cisplatin–DNA–glutathione crosslinks and DNA-monoadducts [16]. The mechanism of CDDP cell toxicity has not been completely elucidated although inhibition of DNA synthesis, synthesis of specific mRNA and generation of active oxygen species have been considered critical for its toxicity 17, 18, 19, 20. A central role for reactive oxygen species (ROI) in cell death has been proposed 21, 22; therefore, the transcriptional factors NF-κB and AP-1, both implicated in the oxidative stress response, could play a role in the apoptotic process.

Recently, we have demonstrated that exposure of HeLa cells to CDDP induces apoptosis. After 18 h of treatment with the drug, these cells undergo specific DNA fragmentation [14]. We investigated the DNA binding activity of the transcriptional factors NF-κB and AP-1 upon CDDP treatment, since they might be implicated in the oxidative stress response [22]and the apoptotic process elicited by this drug 19, 20. We also analyzed the distribution of p53, which is activated by NF-κB [23]and is involved in the apoptotic process in several cell lines. Finally, since Bcl-2 protein has been widely related to cell death and is down-regulated by p53 we also analyzed its expression [24].

Section snippets

Cell culture

Human HeLa cells were maintained as monolayers in DMEM containing 10% (v/v) fetal bovine serum and incubated at 37°C in a humidified atmosphere of a 5% (v/v) CO2 in air. Cells at 70% confluence were treated with 40 μM CDDP. DMEM and fetal bovine serum were obtained from Gibco; CDDP and other chemicals were obtained from Sigma.

Immunoblotting

At the times shown, monolayers were washed twice with PBS to eliminate dead cells. Cell extracts of CDDP-treated cells were prepared by lysis with Laemmli buffer [25].

Results

As previously reported [14], exposure of HeLa cells to CDDP resulted in a time and dose-dependent apoptosis, as stated by morphological features, extensive and specific DNA fragmentation and in situ end-labeling of DNA breaks. To determine whether the treatments with CDDP (40 μM) have any effect in the NF-κB and AP-1 transcriptional factors, we performed electrophoretic mobility shift assays with nuclear extracts prepared from control or treated cells exposed to CDDP for the indicated times.

Discussion

Since the events that lead to the apoptotic cell death following exposure to DNA-damaging agents are not clearly defined, we analyzed the participation of two of the most important nuclear regulators, AP-1 and NF-κB, in apoptotic process in HeLa cells exposed to CDDP. AP-1 binding activity was not modified, excluding a direct participation of this transcriptional complex in the apoptotic process, although it is possible that other specific complexes not detected by the probe could be

Acknowledgements

This work was supported in part by CONACYT REF: F383 and M9304 infrastructure grants.

References (53)

  • C. Abbadie et al.

    High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro

    Cell

    (1993)
  • A. Strasser et al.

    DNA Damage can induce Apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

    Cell

    (1994)
  • C.P. Mansur et al.

    Cellular transformation by papillomavirus oncoproteins

    Biochim. Biophys. Acta

    (1993)
  • A.H. Wyllie

    Apoptosis (The 1992 Frank Rose Memorial Lecture)

    Br. J. Cancer

    (1992)
  • J.F.R. Kerr et al.

    Apoptosis

    Cancer

    (1994)
  • C. Prives et al.

    The p53 tumor suppressor protein: meeting review

    Genes Dev.

    (1993)
  • J.M. Huibregtse et al.

    Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53

    Cell. Biol.

    (1993)
  • P. Benveniste et al.

    p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency

    Proc. Natl. Acad. Sci. USA

    (1995)
  • Y. Wang et al.

    Wild-type p53 triggered apoptosis is inhibited by Bcl-2 in a v-myc-induced T-cell lymphoma line

    Oncogene

    (1993)
  • H. Symond et al.

    p53-dependent apoptosis suppresses tumor growth and progression in vivo

    Cell

    (1994)
  • S. Chiou et al.

    Bcl-2 blocks p53-dependent Apoptosis

    Mol. Cell. Biol.

    (1994)
  • D.J. Kane et al.

    Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species

    Science

    (1993)
  • V. Maldonado et al.

    Internucleosomal DNA cleavage in HeLa Cells exposed to cisplatin

    Biochem. Mol. Biol. Int.

    (1994)
  • A.M.J. Fichtinger-Schepman et al.

    Adducts of the antitumor drug cis-diamminedichloroplatinum (II) with DNA: formation, identification, and quantitation

    Biochemistry

    (1985)
  • C.S. Sorenson et al.

    Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity:role of G2 arrest and DNA double-strand breaks

    Cancer Res.

    (1988)
  • C.M. Sorenson et al.

    Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin

    J. Natl. Cancer Inst.

    (1990)
  • Cited by (0)

    View full text